BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION
What was lobbied
18 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Medicaid Rebates Dual Eligibles Generic Fill Incentives Medicare Prescription Drug Coverage Transfer of Certain Drugs from Part B to Part D Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Biosimilars Implementation of H.R. 3590:(Senate) Patient Protection and Affordable Care Act Reimbursement Issues Funding for National Institutes of Health S.R. 1599: Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations for FY 2012 Funding for Centers for Disease Control and Prevention Vaccine Programs S.R. 1599: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2012 Expansion of 340B Drug Pricing Program Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Diagnostics and Personalized Medicine Regulation and Oversight Therapeutic Discovery Project Tax Credit Extension Rare Pediatric & Tropical Disease Drug Development Drug Safety and Review S. 1584: Drug Safety and Accountability Act of 2011 Prescription Drug User Fee Act (PDUFA) Reauthorization Regulatory Reforms for Innovative Products Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Center for Veterinary Medicine, Scientific Infrastructure) H.R. 2112: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2012 Independent Payment Advisory Board Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement S.R. 1599: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2012 Cures Acceleration Network S. 1599: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2012 Biodefense Research, Development and Procurement (Non-Funding Issues) Pandemic and All-Hazards Preparedness Act Reauthorization HHS Countermeasures Review Drug Shortages H.R. 2245: Preserving Access to Life Saving Medicines Act of 2011 S. 296: Preserving Access to Life-Savings Medicines Act of 2011 TransPacific Partnership Data and Intellectual Property Protection for Pharmaceuticals Reimbursement for Innovative Products Part B Physician-Administered Products Medicare Policies and Regulation
| Lobbyist | Covered position, as disclosed |
|---|---|
| PHYLLIS ARTHUR | — |
| MELISSA BOWIE | — |
| BRENT ALAN DELMONTE | — |
| SANDRA DENNIS | — |
| TOM DILENGE | — |
| ANDREW EMMETT | — |
| ELIZABETH CARTIER ESHAM | — |
| LILA FEISEE | — |
| CHARLES H FRITTS New | — |
| JEANNE HAGGERTY | — |
| TRACEY LATURNER | — |
| SHELLY MUI-LIPNIK | — |
| ALYSON PUSEY New | — |
| SARA RADCLIFFE | — |
| MATTHEW SCHUMAKER | — |
| TOOSHAR SWAIN | — |
| LAUREL TODD | — |
| ANNA KATHERINE WEINSTEIN | — |
| ROY STANFORD ZWAHLEN | — |
Agriculture AGR
Biomass Crop Assistance Program (BCAP) Funding H.R. 2112: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2012 USDA/APHIS Agricultural Biotechnology Regulations Coexistence of Production Systems EPA Regulations on Agricultural Biotechnology EPA Notice on PIP Data Requirements Reauthorization and Implementation of Pesticide Registration Improvement Act Livestock Cloning/Product Labeling Discussions with EU on Animal Cloning Genetically Engineered (GE) Animals H.R. 2112: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2012 Amendment to Restrict FDA Approval of GE Salmon FDA Approval Labeling Export Registrations for Products with Expired Patents U.S. Policy on International Science-Based Regulations Codex Standards TransPacific Partnership Sanitary and Phytosanitary Issues Foreign Agricultural Biotechnology Laws and Regulations International Biotechnology Agreement Discussions with EU on Animal Cloning China Biotechnology Regulations Low-Level Presence Foreign Government Polices European Union Low-Level Presence Policy EU Biotechnology Bilateral Discussions Korea Biotechnology Regulations APEC Agricultural Biotechnology Discussions Regulatory Actions on Biological Pesticides H.R. 872: Reducing Regulatory Burdens Act of 2011 Agricultural Biotechnology Regulatory Reform and Modernization House Agriculture Subcommittee Hearings Potential Regulation of New Genetic Modification Technologies EU Workshop
| Lobbyist | Covered position, as disclosed |
|---|---|
| AB BASU | — |
| BRENT ALAN DELMONTE | — |
| DAVID EDWARDS | — |
| TRACEY LATURNER | — |
| DANA MAURICE O'BRIEN | — |
| MATTHEW O'MARA | — |
Taxation/Internal Revenue Code TAX
Bio-based Products Tax Credit Therapeutic Discovery Project Tax Credit Extension Biofuels Investment Tax Credit Options Biofuels Production Tax Credit Modification for Algae-based Biofuels Biofuels Production Tax Credit Extension Capital Formation Investment Incentives Expansion of Eligibility under SEC Regulation A H.R. 1070: The Small Company Capital Formation Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATT CARR | — |
| SARAH THORNTON CASWELL | — |
| BRENT ALAN DELMONTE | — |
| ALAN EISENBERG | — |
| ELIZABETH CARTIER ESHAM | — |
| CHARLES H FRITTS New | — |
| TRACEY LATURNER | — |
| SHELLY MUI-LIPNIK | — |
| DANA MAURICE O'BRIEN | — |
| MATTHEW SCHUMAKER | — |
| RINA SINGH | — |
| TOOSHAR SWAIN | — |
Science/Technology SCI
Small Business Innovation and Research (SBIR) Program Reauthorization HR 1425: Creating Jobs Through Small Business Innovation Act of 2011 S.493: SBIR/STTR Reauthorization Act of 2011
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRENT ALAN DELMONTE | — |
| ALAN EISENBERG | — |
| ELIZABETH CARTIER ESHAM | — |
| CHARLES H FRITTS New | — |
Clean Air and Water (quality) CAW
IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations Biofuels Department of Defense Applications of Advanced Biofuels (Opposition to Section 526 Repeal)
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATT CARR | — |
| SARAH THORNTON CASWELL | — |
| DANA MAURICE O'BRIEN | — |
| ROY STANFORD ZWAHLEN | — |
Consumer Issues/Safety/Products CSP
Livestock Cloning/Product Labeling Discussions with EU on Animal Cloning USDA/APHIS Agricultural Biotechnology Regulations Coexistence of Production Systems Genetically Engineered (GE) Animals FDA Approval Labeling H.R. 2112: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2012 Amendment to Restrict FDA Approval of GE Salmon Generic Drug Patent Settlements Drug Safety and Review S. 1584: Drug Safety and Accountability Act of 2011 Prescription Drug User Fee Act (PDUFA) Reauthorization Regulatory Reforms for Innovative Products Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Center for Veterinary Medicine, Scientific Infrastructure) H.R. 2112: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2012 Drug Shortages H.R. 2245: Preserving Access to Life Saving Medicines Act of 2011 S. 296: Preserving Access to Life-Savings Medicines Act of 2011
| Lobbyist | Covered position, as disclosed |
|---|---|
| PHYLLIS ARTHUR | — |
| AB BASU | — |
| MELISSA BOWIE | — |
| BRENT ALAN DELMONTE | — |
| SANDRA DENNIS | — |
| TOM DILENGE | — |
| DAVID EDWARDS | — |
| ANDREW EMMETT | — |
| ELIZABETH CARTIER ESHAM | — |
| JEANNE HAGGERTY | — |
| TRACEY LATURNER | — |
| DANA MAURICE O'BRIEN | — |
| SARA RADCLIFFE | — |
| MATTHEW SCHUMAKER | — |
| ANNA KATHERINE WEINSTEIN | — |
Trade (domestic/foreign) TRD
Livestock Cloning/Product Labeling Discussions with EU on Animal Cloning Export Registrations for Products with Expired Patents U.S. Policy on International Science-Based Regulations Codex Standards Intellectual Property International Enforcement TransPacific Partnership Sanitary and Phytosanitary Issues Data and Intellectual Property for Pharmaceuticals Foreign Agricultural Biotechnology Laws and Regulations International Biotechnology Agreement Discussions with EU on Animal Cloning China Biotechnology Regulations Low-Level Presence Foreign Government Policies European Union Low Level Presence Policy EU Biotechnology Bilateral Discussions Korea Biotechnology Regulations APEC Agricultural Biotechnology Discussions Genetic Resource Patent Disclosure Requirement World Intellectual Property Organization Philippines IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations Potential Regulation of New Genetic Modification Technologies EU Workshop
| Lobbyist | Covered position, as disclosed |
|---|---|
| MELISSA BOWIE | — |
| BRENT ALAN DELMONTE | — |
| TOM DILENGE | — |
| DAVID EDWARDS | — |
| LILA FEISEE | — |
| CHARLES H FRITTS New | — |
| JEANNE HAGGERTY | — |
| DANA MAURICE O'BRIEN | — |
| MATTHEW O'MARA | — |
| SARA RADCLIFFE | — |
| MATTHEW SCHUMAKER | — |
| ANNA KATHERINE WEINSTEIN | — |
| ROY STANFORD ZWAHLEN New | — |
Copyright/Patent/Trademark CPT
Patent Reform H.R. 1249: The Leahy-Smith America Invents Act of 2011 S. 23: The Patent Reform Act of 2011 Implementation of H.R. 1249: The America Invents Act of 2011 IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations Generic Drug Patent Settlements Genetic Resource Patent Disclosure Requirement World Intellectual Property Organization Philippines DNA Patenting and Licensing Rep. Wasserman Schultz Amendment to H.R. 1249: The America Invents Act of 2011 Bayh-Dole Act/Tech Transfer Bayh-Dole Act/Tech Transfer Commercialization of Federally Funded Research Initiative Domestic Manufacturing Requirement Intellectual Property International Enforcement TransPacific Partnership Data and Intellectual Property Protections for Pharmaceuticals
| Lobbyist | Covered position, as disclosed |
|---|---|
| MELISSA BOWIE | — |
| BRENT ALAN DELMONTE | — |
| TOM DILENGE | — |
| LILA FEISEE | — |
| CHARLES H FRITTS New | — |
| JEANNE HAGGERTY | — |
| SARA RADCLIFFE | — |
| HANSJORG SAUER | — |
| MATTHEW SCHUMAKER | — |
| ANNA KATHERINE WEINSTEIN | — |
| ROY STANFORD ZWAHLEN New | — |
Small Business SMB
Capital Formation Investment Incentives Sarbanes Oxley Section 404 (b) Exemption Small Company Job Growth and Regulatory Relief Act of 2011 (Discussion Draft) Small Business Innovation and Research (SBIR) Program Reauthorization HR 1425: Creating Jobs through Small Business Innovation Act of 2011 S.493: SBIR/STTR Reauthorization Act of 2011 Small Business Early-Stage Investment Therapeutic Discovery Project Tax Credit Extension Expansion of Eligibility under SEC Regulation A H.R. 1070: The Small Company Capital Formation Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRENT ALAN DELMONTE | — |
| ALAN EISENBERG | — |
| ELIZABETH CARTIER ESHAM | — |
| CHARLES H FRITTS New | — |
| SHELLY MUI-LIPNIK | — |
| MATTHEW SCHUMAKER | — |
| TOOSHAR SWAIN | — |
Medicare/Medicaid MMM
Medicaid Rebates Dual Eligibles Medicare Prescription Drug Coverage Transfer of Certain Drugs from Part B to Part D Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Independent Payment Advisory Board Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Reimbursement for Innovative Products Part B Physician-Administered Products Medicare Policies and Regulation
| Lobbyist | Covered position, as disclosed |
|---|---|
| MELISSA BOWIE | — |
| BRENT ALAN DELMONTE | — |
| SANDRA DENNIS | — |
| JEANNE HAGGERTY | — |
| ALYSON PUSEY New | — |
| SARA RADCLIFFE | — |
| MATTHEW SCHUMAKER | — |
| LAUREL TODD | — |
| ANNA KATHERINE WEINSTEIN | — |
Budget/Appropriations BUD
Funding for Biomass Crop Assistance Program (BCAP) H.R. 2112: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2012 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement S.R. 1599: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2012 Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Center for Veterinary Medicine, Scientific Infrastructure) H.R. 2112: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2012 Funding for Bio-based Products H.R. 2354: The Energy and Water Appropriations Act for FY 2012 H.R. 2219: Department of Defense Appropriations Act for FY 2012 Funding for Biofuels H.R. 2354: The Energy and Water Appropriations Act for FY 2012 H.R. 2219: Department of Defense Appropriations Act for FY 2012 Funding for Centers for Disease Control and Prevention Vaccine Programs S.R. 1599: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2012 Funding for National Institutes of Health Cures Acceleration Network S.R. 1599: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2012 Genetically Engineered (GE) Animals H.R. 2112: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2012 Amendment to Restrict FDA Approval of GE Salmon
| Lobbyist | Covered position, as disclosed |
|---|---|
| PHYLLIS ARTHUR | — |
| AB BASU | — |
| MATT CARR | — |
| SARAH THORNTON CASWELL | — |
| BRENT ALAN DELMONTE | — |
| DAVID EDWARDS | — |
| ANDREW EMMETT | — |
| ELIZABETH CARTIER ESHAM | — |
| TRACEY LATURNER | — |
| DANA MAURICE O'BRIEN | — |
| SARA RADCLIFFE | — |
Energy/Nuclear ENG
Renewable Fuels Standard S.1564: The Renewable Fuel Parity Act of 2011 Biofuels Economic Growth Impact/Potential of Advanced Biofuels Department of Defense Applications of Advanced Biofuels (Opposition to Section 526 Repeal) Investment Tax Credit Options DOE Loan Guarantees and Grants under the Energy Policy Act of 2005 (Implementation and Funding) Economic Growth Impact/Potential of Advanced Biofuels Biofuels Production Tax Credit Modification for Algae-based Biofuels Next Generation Incentives : Farm Bill Reauthorization Biofuels Production Tax Credit Extension Funding for Biofuels H.R. 2354: The Energy and Water Appropriations Act for 2012 H.R. 2219: Department of Defense Appropriations Act for FY 2012 Bio-based Products Expansion of DOE and USDA Loan Guarantee Programs Next Generation Incentives: Farm Bill Reauthorization USDA BioPreferred Program Economic Growth Impact/Potential of Advanced Bio-based Products Tax Credit Funding for Bio-based Products H.R. 2354: The Energy and Water Appropriations Act for 2012 H.R. 2219: Department of Defense Appropriations Act for FY 2012 Renewable Chemicals Farm Bill Reauthorization: DOE Loan Guarantees
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATT CARR | — |
| SARAH THORNTON CASWELL | — |
| BRENT ALAN DELMONTE | — |
| CHARLES H FRITTS New | — |
| TRACEY LATURNER | — |
| DANA MAURICE O'BRIEN | — |
| RINA SINGH | — |
Food Industry (safety, labeling, etc.) FOO
Livestock Cloning/Product Labeling Discussions with EU on Animal Cloning Genetically Engineered (GE) Animals H.R. 2112: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2012 Amendment to Restrict FDA Approval of GE Salmon FDA Approval Labeling
| Lobbyist | Covered position, as disclosed |
|---|---|
| AB BASU | — |
| BRENT ALAN DELMONTE | — |
| DAVID EDWARDS | — |
| TRACEY LATURNER | — |
| DANA MAURICE O'BRIEN | — |
Animals ANI
Livestock Cloning/Product Labeling Discussions with EU on Animal Cloning Genetically Engineered (GE) Animals H.R. 2112: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2012 Amendment to Restrict FDA Approval of GE salmon FDA Approval Labeling
| Lobbyist | Covered position, as disclosed |
|---|---|
| AB BASU | — |
| BRENT ALAN DELMONTE | — |
| DAVID EDWARDS | — |
| TRACEY LATURNER | — |
| DANA MAURICE O'BRIEN | — |
Pharmacy PHA
Medicaid Rebates Dual Eligibles Generic Fill Incentives Medicare Prescription Drug Coverage Transfer of Certain Drugs from Part B to Part D Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Drug Shortages H.R. 2245: Preserving Access to Life Saving Medicines Act of 2011 S. 296: Preserving Access to Life-Savings Medicines Act of 2011
| Lobbyist | Covered position, as disclosed |
|---|---|
| MELISSA BOWIE | — |
| BRENT ALAN DELMONTE | — |
| SANDRA DENNIS | — |
| ANDREW EMMETT | — |
| JEANNE HAGGERTY | — |
| ALYSON PUSEY New | — |
| SARA RADCLIFFE | — |
| MATTHEW SCHUMAKER | — |
| LAUREL TODD | — |
| ANNA KATHERINE WEINSTEIN | — |
Medical/Disease Research/Clinical Labs MED
Cures Acceleration Network S.R. 1599: Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations for FY 2012 Funding for National Institutes of Health S.R. 1599: Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations for FY 2012 Rare Pediatric & Tropical Disease Drug Development Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement S.R. 1599: Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations for FY 2012 Biodefense Research, Development and Procurement (Non-Funding Issues) Pandemic and All-Hazards Preparedness Act Reauthorization HHS Countermeasures Review
| Lobbyist | Covered position, as disclosed |
|---|---|
| PHYLLIS ARTHUR | — |
| MELISSA BOWIE | — |
| BRENT ALAN DELMONTE | — |
| TOM DILENGE | — |
| ELIZABETH CARTIER ESHAM | — |
| JEANNE HAGGERTY | — |
| TRACEY LATURNER | — |
| MATTHEW SCHUMAKER | — |
| ANNA KATHERINE WEINSTEIN | — |
Fuel/Gas/Oil FUE
Renewable Fuels Standard S.1564: The Renewable Fuel Parity Act of 2011 Biofuels Economic Growth Impact/Potential of Advanced Biofuels Department of Defense Applications of Advanced Biofuels (Opposition to Section 526 Repeal) Investment Tax Credit Options DOE Loan Guarantees and Grants under the Energy Policy Act of 2005 (Implementation and Funding) Economic Growth Impact/Potential of Advanced Biofuels Biofuels Production Tax Credit Modification for Algae-based Biofuels Next Generation Incentives : Farm Bill Reauthorization Biofuels Production Tax Credit Extension Funding for Biofuels H.R. 2354: The Energy and Water Appropriations Act for 2012 H.R. 2219: Department of Defense Appropriations Act for FY 2012 Bio-based Products Expansion of DOE and USDA Loan Guarantee Programs Next Generation Incentives: Farm Bill Reauthorization USDA BioPreferred Program Economic Growth Impact/Potential of Advanced Bio-based Products Tax Credit Funding for Bio-based Products H.R. 2354: The Energy and Water Appropriations Act for 2012 H.R. 2219: Department of Defense Appropriations Act for FY 2012 Renewable Chemicals Farm Bill Reauthorization: DOE Loan Guarantees
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATT CARR | — |
| SARAH THORNTON CASWELL | — |
| BRENT ALAN DELMONTE | — |
| CHARLES H FRITTS New | — |
| TRACEY LATURNER | — |
| DANA MAURICE O'BRIEN | — |
| RINA SINGH | — |
Homeland Security HOM
Biodefense Research, Development and Procurement HHS Countermeasures Review Pandemic and All-Hazards Preparedness Act Reauthorization Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement S.R. 1599: Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations for FY 2012
| Lobbyist | Covered position, as disclosed |
|---|---|
| PHYLLIS ARTHUR | — |
| MELISSA BOWIE | — |
| BRENT ALAN DELMONTE | — |
| TOM DILENGE | — |
| JEANNE HAGGERTY | — |
| TRACEY LATURNER | — |
| ANNA KATHERINE WEINSTEIN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.